Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Study Title

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Teva Identifier

TVP-1012/PM101

ClinicalTrials.gov Identifier

NCT00399477

Study Status

Completed

Trial Condition(s)

Parkinson's Disease

Interventions

Drug: rasagiline mesylate |Drug: Rasagiline mesylate plus Mirapex | Drug: Rasagiline mesylate with Levodopa | Drug: Rasagiline mesylate with Requip

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

30 Years and older

Trial Duration

10/01/2006 - 07/01/2007

Phase

Phase 4

Study Type

Interventional